We describe the discovery of sno-lncRNAs, a class of nuclear-enriched intron-derived long noncoding RNAs (lncRNAs) that are processed on both ends by the snoRNA machinery. During exonucleolytic trimming, the sequences between the snoRNAs are not degraded, leading to the accumulation of lncRNAs flanked by snoRNA sequences but lacking 5 0 caps and 3 0 poly(A) tails. Such RNAs are widely expressed in cells and tissues and can be produced by either box C/D or box H/ACA snoRNAs. Importantly, the genomic region encoding one abundant class of sno-lncRNAs (15q11-q13) is specifically deleted in Prader-Willi Syndrome (PWS). The PWS region sno-lncRNAs do not colocalize with nucleoli or Cajal bodies, but rather accumulate near their sites of synthesis. These sno-lncRNAs associate strongly with Fox family splicing regulators and alter patterns of splicing. These results thus implicate a previously unannotated class of lncRNAs in the molecular pathogenesis of PWS.
INTRODUCTION
Small nucleolar RNAs (snoRNAs) are a family of conserved nuclear RNAs (about 70-200 nt) that are usually concentrated in Cajal bodies or nucleoli where they either function in the modification of snRNAs or rRNA, or participate in the processing of rRNA during ribosome subunit maturation (Boisvert et al., 2007; Kiss, 2001; Matera et al., 2007) . There are several hundred known cellular snoRNAs and the great majority of these are encoded in the introns of protein-coding genes (Filipowicz and Pogaci c, 2002) . SnoRNAs are processed from excised and debranched introns by exonucleolytic trimming (Tycowski et al., 1993; Kiss and Filipowicz, 1995) and carry out their functions in complex with specific protein components, forming ribonucleoprotein complexes (snoRNPs) (Kiss, 2001 ). There are two main classes of snoRNAs: box C/D snoRNAs and box H/ACA snoRNAs, both of which serve as guide RNAs complementary to specific target sequences. Box C/D snoRNAs guide 2 0 -Oribose methylation and box H/ACA snoRNAs guide pseudouridine modifications. Box C/D snoRNAs contain four conserved sequence elements: box C (RUGAUGA) and box D (CUGA) near the 5 0 and 3 0 termini, respectively, and an internal copy of each box, called C' and D'.
Some snoRNAs expressed from an imprinted region have been implicated in an important human disease, Prader-Willi Syndrome (PWS) (Sahoo et al., 2008; de Smith et al., 2009; Duker et al., 2010; Cassidy et al., 2012) . While most autosomal genes are expressed biallelically, genomic imprinting causes some to be expressed only from either the paternal or maternal chromosome. The 15q11-q13 region is imprinted, leading to expression of the SNURF-SNRPN gene and downstream noncoding region from the paternal chromosome, while the UBE3A gene is expressed biallelically in most cells, but only from the maternal chromosome in neurons ( Figure 1A ). The long neuron-specific paternal transcript contains at least 148 exons (which along with their introns appear to have arisen by duplications followed by sequence divergence) and spans 470 kb (Runte et al., 2001 ). All paternal transcripts downstream of the SNRPN gene are noncoding and have been considered primarily as precursors for small RNAs (Cavaillé et al., 2000; Royo and Cavaillé , 2008; Runte et al., 2001) . Since the minimal paternal deletion region associated with PWS (108 kb) removes only SNORD109A, the SNORD116 cluster of 29 similar snoRNAs and IPW, the most current published model is that SNORD116 deficiency is the primary cause of disease (Sahoo et al., 2008; de Smith et al., 2009; Duker et al., 2010) . The function of SNORD116s is unknown. While most snoRNAs exhibit complementarity to rRNA or snRNA targets, it is noteworthy that even after numerous attempts, no noncoding RNA, pre-mRNA or mRNA targets for any of the SNORD116 snoRNAs from 15q11-q13 have been confirmed. These snoRNAs show minimal complementarity to rRNA or other RNAs so far and show greater homology to one another than to other snoRNAs. A few potential targets have been predicted bioinformatically, but none has been validated (Bazeley et al., 2008) . The human and mouse SNORD116s are similar but not identical (even in putative targeting regions), but their deficiency in the mouse recapitulates some of the features of PWS (Skryabin et al., 2007) . This has led to some confusion in the field as to what the precise molecular cause of PWS is.
Increasing lines of evidence have demonstrated that long noncoding RNAs (lncRNAs) are involved in gene regulation and human diseases (Wang and Chang, 2011; Chen and Carmichael, (A) sno-lncRNAs from the imprinted region of chr15. Top, diagram of the region. Transcription of SNURF-SNRPN (blue) and downstream noncoding region (green) occurs only from the paternal chromosome and consists of one or two long primary transcripts containing more than 100 exons. UBE3A (red) is expressed bi-allelically in most cell types, but only from the maternal chromosome in neurons. The 15q11-q13 region is implicated in PWS and the minimal known deletion that results in the disease is shown. The PWS deletion region is known to express SNORD109A, the SNORD116 cluster of 29 snoRNAs and IPW. Middle, transcripts mapping to this region in H9 cells. Poly(A) + reads (black) map to known exons. Note the very high expression of long poly(A)-RNAs (red and boxed)
that we have named sno-lncRNA1-5. The ends of these RNAs map to locations of the indicated snoRNAs. Bottom, a schematic enlarged view of sno-lncRNA3.
Note that the ends of it map precisely to the intron-imbedded snoRNAs 18 and 19 from the SNORD116 cluster.
2010). The majority of lncRNAs are transcribed from intergenic regions Khalil et al., 2009) , promoters (Hung et al., 2011) and enhancers (Ørom et al., 2010) . Few, however, have been shown to derive from introns (for example, see Rearick et al., 2011; Salzman et al., 2012; Yang et al., 2011) . Such molecules would be expected to lack both 5 0 cap structures and 3 0 poly(A) tails. We report here the discovery of a class of lncRNAs whose ends correspond to positions of intronic snoRNAs and which we have named snoRNA-related lncRNAs (sno-lncRNAs). We characterize the sno-lncRNAs from the PWS critical region of chr15 and demonstrate that at least some of these associate strongly with the splicing factor Fox2 and can alter splicing patterns in cells. Thus, these lncRNAs are implicated in the pathogenesis of an important human disease.
RESULTS

Sno-lncRNAs Are Produced from Introns with Two Imbedded snoRNA Genes
We recently used deep sequencing to investigate the nonpolyadenylated, or ''poly(A)-,'' transcriptomes of HeLa cells and human embryonic stem (ES) cells (Yang et al., 2011) . Specifically, we depleted both poly(A) + and ribosomal RNAs, performed size selection (>200 nt), and identified reads that uniquely aligned to the human genome. This allowed us to exclude from our analysis poly(A) + RNAs, rRNAs, abundant short RNAs (microRNAs, piRNAs, and siRNAs), tRNAs, small nuclear RNAs (snRNAs), many snoRNAs and repetitive transcripts such as the abundant Alu elements, LINE elements and endogenous LTRs. In this work we identified a number of intron-derived long noncoding RNAs that appeared to represent stable excised introns (Yang et al., 2011) . Furthermore, after careful analysis we discovered an unusual class of lncRNAs (sno-lncRNAs) whose ends correspond to positions of intronic snoRNAs ( Figures 1A and S1 ).
The most abundant sno-lncRNAs in human ES cells (H9) are expressed from the imprinted 15q11-q13 region ( Figure 1A ). Strikingly, in H9 cells at least five unannotated poly(A)-lncRNAs in the PWS region are expressed at extremely high levels (similar in abundance to some histone mRNAs) ( Figure 1A ). The deep sequencing data suggested that the ends of these molecules correspond precisely to intron-imbedded snoRNA genes and each molecule appears to derive from an intron containing two snoRNAs, one at each end ( Figure 1A , bottom, and Figures S1-S3).
Northern blots ( Figures 1B and 1C ) demonstrated that fulllength sno-lncRNA molecules of the expected sizes from this region are expressed in many different cell types, being especially abundant in pluripotent cells such as human ES H9 cells and ovarian carcinoma PA1 cells, but not expressed or expressed at low levels in HeLa cells ( Figure 1C ) and some other lines ( Figure S4A ). In addition, the PWS region sno-lncRNAs are widely expressed in many human tissues ( Figure 1D) , consistent with what is known of the expression from the 15q11-q13 region.
Since both classes of snoRNAs (box C/D and box H/ACA snoRNAs) are processed from excised and debranched introns by exonucleolytic trimming (Kiss and Filipowicz, 1995; Tycowski et al., 1993) , we reasoned that introns containing two imbedded H/ACA box snoRNAs should also be capable of generating sno-lncRNAs. This is indeed the case ( Figure S3 ), further highlighting the generality of this previously unreported class of intron-derived lncRNAs.
Box C/D sno-lncRNAs Are Processed Using the snoRNP Machinery Deep sequencing and Northern blotting results suggested that the sno-lncRNAs from the 15q11-q13 region contain snoRNA sequences at each end. This is further supported by Northern blotting using probes to individual snoRNAs from this region. Figure 2A shows that probes specific for each of the snoRNAs flanking sno-lncRNA2 not only reveal the annotated and reported snoRNAs (SNORD116-13 and SNORD116-14), but also the full-length sno-lncRNA2. We do not yet know whether this sno-lncRNA can serve as precursor for further processing to snoRNAs, or whether alternative splicing in this region (see Figure S1 ) leads to introns containing SNORD116-13 and SNORD116-14 individually.
Box C/D snoRNAs contain four conserved sequence elements: box C (RUGAUGA) and box D (CUGA) near the 5 0 and 3 0 termini, respectively, and a slightly less conserved internal copy of each box, called C' and D'. SnoRNAs are processed and carry out their functions in complex with specific protein components, forming ribonucleoprotein complexes (snoRNPs) (Kiss, 2001) . Motif analysis of snoRNA sequences in all five PWS region sno-lncRNAs revealed they contain the conserved C/D boxes, but internal sequences between the snoRNAs are not very well conserved among the molecules (data not shown).
In conjunction with splicing, intron-encoded box C/D snoRNA sequences become associated with two of the four specific snoRNP proteins: 15.5K protein and Fibrillarin (Hirose et al., 2003) . We therefore asked whether these proteins are associated with box C/D sno-lncRNAs. Immunoprecipitation confirmed that all five PWS region sno-lncRNAs can be immunoprecipitated with anti-Fibrillarin antibodies ( Figure 2B ), while a number of control RNAs, including a box H/ACA sno-lncRNA, are not. Furthermore, we expressed and purified a sno-lncRNA containing binding sites for the MS2 coat protein and found that both (B) PWS region sno-lncRNA1, 2, 4 and 5 are highly expressed in human ES H9 and EC PA1 cells. Total RNA was isolated from each indicated cell line and resolved on an agarose gel. The probes for NB (red bar in A) were located in the internal sequence between two snoRNAs of each sno-lncRNA. Each sno-lncRNA from the PWS region can only be detected by an individual antisense probe and expression levels in these two cell lines are comparable. Equivalent amounts of RNA from H9 and PA1 cells were loaded as indicated by 28S and 18S rRNAs. (A) snoRNAs and sno-lncRNAs can both be produced from the same genomic locus. The probes for NB are located in each snoRNA of sno-lncRNA2 and these probes can detect both sno-lncRNA2 and snoRNAs. (B) PWS region sno-lncRNAs are associated with snoRNP complexes. Top, RIP was performed from PA1 cells using anti-Fibrillarin, IgG, and empty beads followed by RT-qPCR. Bar plots represent fold enrichments of RNAs immunoprecipitated by anti-Fibrillarin or IgG over empty beads, and error bars represent SD in triplicate experiments. Bottom, another key component of the snoRNP complex, 15.5K, associates with the same complexes. (C) SnoRNP proteins are associated with sno-lncRNAs. Top left, sno-lncRNA2 (for simplicity, referred to as sno-lncRNA in panels C and D) was inserted into the intron region of egfp mRNA such that only proper splicing leads to EGFP fluorescence (Top right, a schematic view of the vector used). Bottom left, total RNAs were collected from the same batch of transfected cells and resolved on agarose gels for NB. Note that both wt and the one containing an insert with 6ms2 were processed to stable sno-lncRNAs. Bottom right, MS2-MBP pulldown was performed from transfected HeLa cells, followed by WB with antibodies to Fibrillarin, 15. Fibrillarin and 15.5K protein can be copurified with the sno-lncRNA ( Figure 2C ). Taken together, these data suggest that sno-lncRNAs are generated using the same machinery involved in snoRNP biogenesis and that snoRNP components remain associated with them. In order to learn more about the mechanism of processing of sno-lncRNAs, we constructed sno-lncRNA expression vectors in which the C and D' boxes or the C' and D boxes of the snoRNAs at both ends were deleted (Figures 2D). Results clearly show that the C and D' boxes of the snoRNA at the 5 0 end and the C' and D boxes of the snoRNA at the 3 0 end are critical for both sno-lncRNA processing and pre-RNA stabilization ( Figure 2D , lanes 1 and 4), while other deletions still result in the proper processing of sno-lncRNAs, although with reduced efficiency ( Figure 2D, lanes 2 and 3) . Further mutagenesis revealed that the deletion of the C box at the very end of the 5 0 snoRNA and the D box at the very end of the 3 0 snoRNA completely block sno-lncRNA generation, while pre-RNA expression remains unchanged ( Figure 2D , lanes 5 and 8). These data further confirm that the processing of sno-lncRNAs requires essential motifs of snoRNA molecules at each end.
Analysis of histone modifications of the SNRPN region using the ENCODE ChIP-Seq from human ES cells (H1) and neuronal NH-A cells revealed that sno-lncRNAs likely do not contain their own promoters but rather derive from a longer SNRPN transcript ( Figure S4C ). Taken together with the known processing of snoRNAs from excised, debranched introns by exonuclease trimming, these considerations lead us to propose the model for sno-lncRNA processing shown in Figure 2E . In this model, introns that contain two snoRNAs are processed from their ends; however, the internal sequences between snoRNAs are not removed, leading to the accumulation of long noncoding RNAs with snoRNP ends. Processing could occur in two ways, leading to linear RNAs with snoRNP structures at both ends, or ''circularized'' molecules resembling normal snoRNP structures but with very long internal inserts ( Figure 2E ). While our results are also consistent with the ''circularized'' model, we favor the model where naturally occurring sno-lncRNAs have canonical snoRNP structures at both ends. The presence of snoRNPs at each end could enhance the stability of these RNAs by inhibiting exonucleolytic degradation. In fact, we found these PWS region sno-lncRNAs to be quite stable. After treatment of PA1 cells with alpha-amanitin or Actinomycin D, we observed sno-lncRNAs 2,3 and 4 to remain virtually unchanged for at least 24 hr. SnolncRNAs 1 and 5 were somewhat less stable, with half lives of 12-16 hr (data not shown), consistent with their lower relative abundances in PA1 cells.
Localization of PWS Region sno-lncRNAs
Since they are processed from introns and are not polyadenylated (Figures 1, S1 , S3, and S4B), we expected sno-lncRNAs to be localized to the nucleus. By nuclear/cytoplasmic RNA fractionation ( Figure S4D ) and RNA in situ hybridization, we found that the PWS region sno-lncRNAs are nuclear retained and each exhibits striking localization to primarily a single or two closely positioned subnuclear sites in multiple cell lines (Figures 3, S5A , and S5B). Intriguingly, our results also revealed that all five PWS region sno-lncRNAs accumulate to the same places in the nucleus ( Figures 3A and S5A ). This is consistent with a common function and/or a common fate of these sno-lncRNAs. Most snoRNPs localize to the nucleolus, which may reflect their normal targeting of rRNAs (Boisvert et al., 2007; Kiss, 2001; Matera et al., 2007) , and many C/D box snoRNAs, proteins and Fibrillarin are also enriched in Cajal bodies (CBs). However, sno-lncRNAs do not accumulate in either nucleoli or CBs ( Figure 3B ), suggesting that they are functionally distinct from classical C/D box snoRNAs. This suggests that these sno-lncRNAs do not traffic through or encounter CBs or nucleoli as is the case for canonical snoRNAs. Double DNA/ RNA FISH ( Figure 3C ) suggests that PWS region sno-lncRNAs accumulate at or near their sites of processing. In both H9 and PA1 cells, sno-lncRNAs colocalize with the site of one of their genes, consistent with the fact that they are expressed only from the paternal chromosome. Interestingly, when expressed from a plasmid expression vector, sno-lncRNA localizes to numerous nuclear sites, likely representing sites of plasmid transcription ( Figure S5C ).
Knockdown of PWS Region sno-lncRNAs Has Little Effect on Global Gene Expression
As sno-lncRNAs represent an unannotated class of molecules, we were interested in exploring their possible functions. Their exceptionally high expression in some cells and their localization to sites of their processing first suggested a possible role in chromatin organization or local gene expression. Since all PWS region sno-lncRNAs accumulate together, we optimized different combinations of phosphorothioate-modified antisense oligodeoxynucleotides (ASOs) (Figures 4 and S6) to knock down all five sno-lncRNAs simultaneously. We were able to knockdown all five to about 20%-30% of their normal levels in PA1 cells ( Figure 4A ). Figure 4B further illustrates the knockdown of sno-lncRNA2. This significant but incomplete knockdown resulted in fewer and smaller nuclear dots seen by FISH: about 60% of cells in which sno-lncRNAs were knocked down completely lost detectable nuclear accumulations ( Figure 4C ), while 40% of these cells contained smaller nuclear dots compared to control cells ( Figures 4D and S6D) . Further, knocking down sno-lncRNAs had no significant effect of the formation of snoRNAs ( Figure S6E ). If these lncRNAs played a role in gene expression from the PWS region, we would have expected to observe an altered level of snurf-snrpn transcription. However, this was not the case and we observed only slight decrease of expression across the SNURF-SNRPN gene ( Figure 4E ). This suggests that although they primarily accumulate to their sites of synthesis ( Figure 3C ), the PWS region sno-lncRNAs could be functionally distinct from other lncRNAs, such as xist, which snoRNA in the 3 0 end. Note that deletions of #1, 4, 5, and 8 impede sno-lncRNA processing (red box). The upper band of sno-lncRNA in NB is from aberrant splicing (data not shown). The relative abundance of pre-RNA and processed sno-lncRNA from each transfection was determined using Image J and labeled underneath.
(E) A model for sno-lncRNA processing. See text for details.
have a profound role in regulating gene expression in cis by recruiting chromatin modeling complexes (Augui et al., 2011) . In fact, these PWS region sno-lncRNAs are less tightly associated with chromatin when compared to xist, as revealed by subnuclear fractionation (Figure 3D ), further supporting the notion that these sno-lncRNAs exert their functions differently from many other known chromatin associated lncRNAs.
To further examine whether these sno-lncRNAs could affect gene expression from other regions of the genome, RNAs from duplicate experiments using scrambled or specific ASO-treated cells were collected for RNA-seq analyses. Since the correlation between two biological repeats was greater than r 2 = 0.95 ( Figure S7A ), we combined data from replicates for further analysis. Interestingly, however, in this entire set of data, we identified only a very small number of genes whose expression changed significantly after sno-lncRNA knockdown ( Figure 4F and Tables S1 and S2). Importantly, these changes observed in the RNA-seq data were further validated by RT-qPCR (Fig- ure 4G). Interestingly, one of the most affected genes, BIRC6, is known to play a crucial function in cell division (Hao et al., 2004) and promotes hippocampal neuron survival (Sokka et al., 2005) , suggesting a possible role in PWS neurocognitive defects.
PWS Region sno-lncRNAs Are Associated with Splicing Factor Fox2
Further insights into the potential function of sno-lncRNAs was suggested by crosslinking and immunoprecipitation followed by deep sequencing (CLIP-seq) data from human ES cells using antibodies to Fox2, which revealed that transcripts from the SNORD116 region are strongly bound by Fox2 (Yeo et al., 2009 ). The Fox family of alternative splicing regulators contains three paralogs: Fox1 (also called A2BP1), Fox2 (also called RBM9) and Fox3 (also called HRNBP3 and NeuN). Fox2 is widely expressed in tissues, but Fox1 and Fox3 are most highly expressed in the brain Nakahata and Kawamoto, 2005; Underwood et al., 2005) . These proteins act as alternative splicing regulators and have been shown to act by binding to the hexanucleotide motif UGCAUG (Kim et al., 2009; Underwood et al., 2005) , but can also recognize GCAUGU, GUGAUG, UGGUGA and GGUGGU (Yeo et al., 2009 ). In addition, these factors may be involved in alternative polyadenylation, mRNA stability, localization and translation (Shi et al., 2009; Wang et al., 2008) . Interestingly, each sno-lncRNA from the 15q11-q13 region contains multiple binding sites for Fox2 and one of the very strongest regions of interaction of Fox2 in the entire genome (Yeo et al., 2009 ) mapped precisely to sno-lncRNA1 in H9 cells (Figures 5A,  S7B ). We confirmed that Fox2 directly interacts with these sno-lncRNAs using immunoprecipitation of Fox2 followed by RT-qPCR ( Figure 5B ) and by purification of a sno-lncRNA containing binding sites for the MS2 coat protein followed by Western blotting with Fox2 antibodies ( Figure 5C ). Additional colocalization of sno-lncRNA and Fox2 in both H9 cells and PA1 cells revealed that the nuclear Fox2 is strongly enriched in nuclear accumulations containing sno-lncRNAs ( Figure 5D ), suggesting binding of sno-lncRNAs could locally redistribute Fox2 to specific subnuclear neighborhoods.
PWS Region sno-lncRNAs Alter Fox-Regulated Splicing
The strong association of Fox2 with sno-lncRNAs suggested at least two possibilities. First, Fox2 may be necessary for the expression of at least some sno-lncRNAs. In this model, the splicing events that give rise to sno-lncRNAs may themselves rely on, or be influenced by, the expression of Fox proteins. Thus, these splicing factors could alter splicing patterns to make different sno-lncRNA expression. Fox2 but not Fox 1 or Fox3 is expressed in H9 (Yeo et al., 2009 ) and PA1 cells ( Figure 5E and Table S1 ); however, knockdown of Fox2 ( Figure 5F ) had no significant effect on sno-lncRNA expression ( Figure 5G ). The second formal possibility is that sno-lncRNAs influence Fox2-mediated splicing regulation. Given the facts that each sno-lncRNA contains multiple consensus binding sites for Fox2 (Figures 5A and S2) , that the expression level of these sno-lncRNAs is high in pluripotent cells and in neurons (Figure 1) , and that all five PWS region sno-lncRNAs accumulate to the same places in the nucleus (Figures 3, 5D , and S5), we hypothesized that at least some sno-lncRNAs may act as molecular sinks that titrate Fox proteins in specific cells thereby inducing subtle alterations in splicing patterns of Fox-regulated exons. To test the hypothesis that PWS region sno-lncRNAs may functionally alter Fox-regulated splicing, we used our RNA-seq data to analyze the splicing patterns of Fox-regulated cassette exons as reported previously and found that after knockdown of PWS region sno-lncRNAs some of these cassette exons exhibited consistent changes, while the level of expression of each gene remained unaltered ( Figures 6A and  S7C) . More importantly, a number of altered exons were affected in opposite ways by depletion of PWS region sno-lncRNAs or by knockdown of Fox2 ( Figure 6A ), further supporting the hypothesis that PWS region sno-lncRNAs act as molecular sinks for Fox2. The fact that we have so far observed only subtle splicing alterations is quite likely due both to an incomplete simultaneous knockdown of all five sno-lncRNAs ( Figure 4A ) and to the fact that sno-lncRNA expression relocalizes some but not all nuclear Fox2 ( Figure 5D ). Taken together, the current results are consistent with a model in which the binding of sno-lncRNAs to Fox2 act locally to alter splicing patterns in specific subnuclear neighborhoods rather than throughout the nucleus ( Figure 6B ).
DISCUSSION
We report the discovery of a previously unannotated class of nuclear RNA molecules which are processed using the endogenous snoRNA biogenesis machinery. These sno-lncRNAs most likely eluded previous detection because they are long, derive from introns and lack poly(A) tails. Some of the sno-lncRNAs map to a genomic location responsible for Prader-Willi Syndrome, raising the possibility that understanding their function may lead to distinct insights into the pathogenesis of this disease. The most abundant sno-lncRNAs in pluripotent cells are those from the PWS region and are processed from five introns, each of which contains two snoRNA genes. Interestingly, while it has been reported that efficient box C/D type snoRNP processing often requires that the snoRNA gene be positioned near the 3 0 splice site (Hirose et al., 2003; Hirose and Steitz, 2001) , this is clearly not the case for any of the PWS region snoRNAs. In each case, the proximal snoRNA gene is positioned close to the 5 0 splice site. In contrast, the distal snoRNA genes are far from the 3 0 splice sites. We do not yet know whether these characteristics are mechanistically connected to the efficiency of processing or stability of the PWS region sno-lncRNAs.
While snoRNAs are known to localize to Cajal bodies or nucleoli, this is not true for the PWS region sno-lncRNAs (Figure 3B) . The colocalization revealed by DNA and RNA double FISH ( Figure 3C ) demonstrates an accumulation of these molecules near their sites of synthesis. However, as these sno-lncRNAs are less tightly associated with chromatin (Figure 3D) , their localization could also reflect previously unknown subnuclear structures that remain to be dissected. Also, it is quite possible that sno-lncRNAs expressed from sites elsewhere in the genome may not only have different molecular functions, but may localize to different sites within the nucleus. In addition, the nonpolyadenylated RNA sequencing from HeLa and H9 cells revealed a differential expression pattern of the PWS (A) Sno-lncRNAs contain multiple consensus binding sites for Fox family splicing factors (Yeo et al., 2009 ). The relative expression of each snolncRNA in H9 cells is shown (normalized value from the Solexa deep sequencing; Yang et al., 2011) . The relative expression of gapdh and fox2 in the same sample is also shown. (B) PWS region sno-lncRNAs are associated with Fox2. RIP was performed from PA1 cells using anti-Fox2 antibody, IgG, and empty beads, followed by RT-qPCR analyses. Bar plots represent fold enrichments of RNAs immunoprecipitated by anti-Fox2 or IgG over empty beads, and error bars represent SD in triplicate experiments. (C) Fox2 is associated with PWS region snolncRNAs. MS2-MBP pull-down was carried out as described in Figure 2C . Sno-lncRNA-6ms2 specifically brings down Fox2, but not the general splicing factor SRSF2. region sno-lncRNAs, suggesting more similar genomewide analyses will be required to further identify more types of sno-lncRNAs in different cells.
The global analyses of PWS region sno-lncRNA knockdown revealed no dramatic changes in cellular gene expression, consistent with the observation that their lack of expression in PWS patients is not lethal. However, some Fox-regulated cassette exons showed inclusion/exclusion alterations after sno-lncRNA knockdown (Table S3 and Figure 6A ), consistent with a model whereby the PWS region sno-lncRNAs act as molecular sinks. It is interesting to note that among the group of genes most affected by PWS region sno-lncRNA knockdown are several with a clear connection to neuronal function (Table  S3 ). For example, Neuronal ankyrin 2 (ANK2) is expressed preferentially in the brain (Otto et al., 1991) . In addition, PTPRZ1, a protein tyrosine phosphatase, binds specifically to members of the Contactin family of neural adhesion molecules which modulate oligodendrogenesis (Lamprianou et al., 2011) , and GIT1 is associated with attention deficit hyperactivity disorder (Won et al., 2011) . Subtle changes of splicing regulation of these cassette exons during early embryonic development and adulthood may result in an abnormal development in PWS patients.
A role as sinks for RNA-binding proteins would place PWS region sno-lncRNAs in a similar category with a number of other lncRNAs. For example, the Drosophila heat shock-induced RNA hsr-omega sequesters RNA binding proteins (Jolly and Lakhotia, 2006) , CUG repeats sequester CUGBP1 and MBNL1 (de Haro et al., 2006; Fardaei et al., 2001) , stress-induced SatIII sequesters hnRNP proteins (Valgardsdottir et al., 2008) , NEAT1 and MALAT1 have many binding sites for TDP-43 (Polymenidou et al., 2011; Tollervey et al., 2011) and MALAT1 binds many SR proteins and modulates alternative splicing (Tripathi et al., 2010) .
Taken together, our data lead us to hypothesize that one or more of the sno-lncRNAs from the PWS region are functionally connected to this disease by acting as molecular sinks for Fox proteins ( Figure 6B ). It was recently reported that aberrant expression of Fox1 is generally associated with a variety of autisms (Voineagu et al., 2011) . This may relate to PWS and to the fact that PWS critical region transcripts bind strongly to Fox2 in H9 cells (Yeo et al., 2009 ) and, by inference, will likewise bind strongly to Fox1 in the brain, and to both in other tissues. However, the observation that sno-lncRNA knockdown leads to altered expression levels of some genes ( Figure 4G ) leads us to emphasize that Fox protein titration may not be the only function for these sno-lncRNAs and more work is warranted to learn about additional protein partners and functions.
EXPERIMENTAL PROCEDURES
Cell Culture, Plasmid Construction and Cell Transfection All human cell lines were cultured using standard protocols. Full length sno-lncRNA2 flanked by its natural intron, splicing sites and exons was cloned into pcDNA3, and then subcloned into the EGFP reporter pZW1 (Wang et al., 2004) . All deletions and mutations of snoRNA genes in sno-lncRNA2 in the vector pcDNA3-sno-lncRNA2 were created using the QuikChange SiteDirected Mutagenesis Kit (Stratagene). Transfection was carried out with either X-tremeGENE 9 (Roche) according to the manufacturer's protocols.
Total RNA Isolation, Human Tissue RNA Samples, RT-PCR, RT-qPCR, and Northern Blotting Total RNAs from cultured cell lines were extracted with Trizol (Invitrogen). 20 human tissue RNA samples were purchased from Ambion. For RT-PCR, after treatment with DNase I (Ambion, DNA-freeÔ kit), the cDNA was transcribed with SuperScript II (Invitrogen). For qPCR, the relative expression of different sets of genes was quantified to actin mRNA. Northern blots were performed with Digoxigenin labeled antisense probes (DIG Northern Starter Kit, Roche). (A) Knockdown of sno-lncRNAs affects splicing of some Fox2-regulated cassette exons. Left, heatmap of affected Fox2-regulated cassette exons and the relative expression of their corresponding genes after knockdown of all sno-lncRNAs (log2 ratio). The relative change of alternative splicing of each affected cassette exon is shown on the left column of the heatmap. Note that in most cases the expression of exons is altered, while that of the genes is not. Right, cassette exons affected by knockdown of sno-lncRNAs (left) were randomly selected and tested for their alternative splicing after knockdown of Fox2 using semiquantitative RT-PCR. Note that knockdown of Fox2 results in more exclusion of cassette exons from ANK2, NFATC3, and PLCB4, while more inclusion of cassette exons from MBNL1 and EXOC1. (B) A model for the role of sno-lncRNAs in normal cells and in Prader-Willi Syndrome. Left, in normal pluripotent cells and other cells, high expression of the PWS region sno-lncRNAs leads to the sequestration of Fox family splicing regulators. One possible outcome of this sequestration could be reduced availability of Fox proteins throughout the nucleus, leading to global changes in alternative splicing regulation. Another and non-mutually exclusive outcome is that the local concentration of Fox proteins in the neighborhood of sno-lncRNAs is increased, leading to localized effects on alternative splicing. Right, in PWS patients, where the PWS region sno-lncRNAs are deleted or not expressed, Fox proteins are more uniformly distributed throughout the nucleus, resulting in altered patterns of splicing regulation during early embryonic development and adulthood.
Nuclear/Cytoplasmic RNA Fractionation, Nuclear Soluble/Insoluble RNA Fractionation and Polyadenylated/Nonpolyadenylated RNA Separation Nuclear and cytoplasmic RNA isolation was performed as described (Chen and Carmichael, 2009) . Nuclear soluble and insoluble RNA fractionation was performed with slight modifications according to Cabianca et al. (2012) . Polyadenylated and nonpolyadenylated RNA separation was carried out as described (Yang et al., 2011) .
RNA In Situ Hybridization and Immunofluorescence Microscopy RNA ISH was carried out as described (Chen and Carmichael, 2009 ) with slight modifications. Hybridization was carried out using in vitro transcribed digoxigenin labeled antisense probes and images were taken with a Leica TCS SP5 microscope. The diameters of sno-lncRNAs nuclear accumulation in scramble or pooled ASOs treated cells were measured and boxplots were plotted using a custom R script. For colocalization studies, cells were fixed for 5 min in 2% formaldehyde after RNA ISH, and immunofluorescence were performed with Rabbit anti-Fox2 (1:100, Bethyl), rabbit anti-Nucleolin (1:100, Santa Cruz Biotechnology) or mouse anti-Coilin (1:100, Sigma). The nuclei were counterstained with DAPI. All experiments were repeated at least three times.
RNA/DNA FISH Sequential RNA/DNA FISH experiments were carried out. After RNA ISH, cells were denatured and then hybridized with denatured fluorescence labeled BAC clones recognizing chr15q11.2-12 region (Empire Genomics) overnight. After hybridization and washes, image analyses were performed on single Z stacks acquired with an Olympus IX70 DeltaVision RT Deconvolution System microscope. Signals colocalization was detected in >98% double positive cells.
RNA-Protein Complex Immunoprecipitation
RNA-protein complex immunoprecipitations were carried out as described (Chen and Carmichael, 2009 ). Primary antibodies used in this study were rabbit anti-Fox2 (Bethyl Laboratories), rabbit anti-Fibrillarin (Abcam), and purified rabbit IgG (Sigma).
Protein-RNA Complex Immunoprecipitation by MS2-MBP HeLa cells were transfected with indicated plasmid before harvest. Cell pellets were resuspended in IP buffer and subjected to gentle sonication and centrifuged to obtain cell extracts. The supernatant was first incubated with MS2-MBP and then amylose resin beads (NEB) at 4 C followed by thorough washes. The protein components of sno-lncRNPs were eluted from beads with IP buffer supplemented with 12 mM Maltose, and were checked by WB with different antibodies.
Antisense Oligonucleotide Treatment
Single antisense oligonucleotides (ASOs) or combined ones were introduced to PA1 cells by nucleofection (Lonza) according to the manufacturer's protocol. Renucleofection was performed to increase the knockdown efficiency at 36 hr after the first ASO treatment. Total RNAs were collected for Illumina sequencing and RT-qPCR.
RNA-Seq, Gene Expression, and Splicing Analysis Forty and forty-seven million 1X100 single reads from two biological replicates of each sample were analyzed as described (Yang et al., 2011) . Normalized gene and exon expression levels were determined in units of BPKM and correlations of gene expression among different samples were calculated with custom R scripts. A full list of gene expression is in Table S1 . Altered gene expression was compared between ASO scramble and knockdown treatments with BPKM R 1. Further criteria for scoring were that the fold change of BPKM value of knockdown versus the BPKM value of scramble must be >1.5 or <0.7 and the p-value of fold change must be <0.05 (Table  S2) . Validation of gene expression was carried out with RT-qPCR. The known Fox-regulated alternative splicing events affected by knockdown of sno-lncRNAs were identified from the RNA-seq data using the following criteria: (1) fold change of each Fox-regulated cassette exon must be >1.3 or <0.7; (2) the p-value of fold change must be <0.05; (3) the expression of each gene was not altered. See Figure S7 for examples and Table S3 for details.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, four tables, Supplemental Experimental Procedures, and Supplemental References and can be found with this article online at http://dx.doi.org/10.1016/j.molcel.2012.07.033.
